(EWTX) - Corporate News

(EWTX) – Corporate News

Apr 15, 2024 04:06 PM Edgewise Therapeutics (EWTX) Announces Positive Two-Year Topline Results from ARCH Open Label Trial of Sevasemten in Adults with Becker Muscular Dystrophy
Feb 13, 2024 08:02 AM Edgewise Therapeutics (EWTX) Receives U.S. FDA Fast Track Designation for EDG-5506 for the Treatment of Duchenne Muscular Dystrophy
Jan 19, 2024 08:38 AM
Nov 30, 2023 08:06 AM
Oct 26, 2023 08:03 AM
Jun 26, 2023 04:01 PM
Mar 30, 2023 04:01 PM
Mar 6, 2023 08:04 AM
Dec 20, 2022 09:04 AM
Oct 13, 2022 04:30 PM
Sep 14, 2022 05:44 AM
Sep 13, 2022 08:50 AM
Sep 12, 2022 05:37 AM
Sep 7, 2022 08:01 AM
Apr 4, 2022 06:04 AM
Jan 5, 2022 08:08 AM
Aug 16, 2021 09:01 AM
Mar 26, 2021 06:05 AM